tykhr
sign in
free sign up
Finch Therapeutics Group Inc
Biotechnology
Healthcare
FNCH
1.60 B shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
3.65
52 week high
11.50
high
3.88
52 week low
1.34
low
3.30
growth
-53.75 %
previous Close
3.61
P/E ratio
market cap
10.59 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-6.95 M
89.13 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
-695000000.00 %
59756.00 %
operating incoming
-9.88 M
-133.14 %
net change in cash
0.00 %
cash on hand
34.05 M
-18.31 %
cost of revenue
0.00 %
top